MBP 3.23% 3.0¢ metabolic pharmaceuticals limited

successful trial results for world-first obesity d, page-4

  1. fra
    82 Posts.
    Congratulations to the faithful


    Reading the announcement suggests this is a world class drug.

    Results are better in this trial than for the market leader in terms of side effects (none appear to be noted)and weight loss compared to placebo over the same period.

    Majors have to deal with them now.They have no choice if they wish to remain competitive in this area.Metabolic is indispensable.

    Congrats all.

 
watchlist Created with Sketch. Add MBP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.